Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE pre-emptive pharmacogenomic testing trial
NL-OMON50620Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of flecainide, propafenone, codeine, tramadol, capecitabine and 34 more in adverse drug reaction (ADR), sponsored by Leiden University Medical Center. Started Mar 2017; status: recruiting.
02
Drugs
flecainidepropafenonecodeinetramadolcapecitabine
03
Conditions
adverse drug reaction (ADR)
Beyond the preview
Go deeper on NL-OMON50620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50620.